For LIHC, METTL1, the key component of the m7G methyltransferase complex, was disclosed to be upregulated in LIHC and can promote tumor progression via m7G tRNA modification-dependent translation control (Chen et al., 2021). The gene discussed is METTL1; the disease is neoplasm.